Scarica l'app Stockscreener
9.68
2.03%
-0.17
Precedente Chiudi:
$9.85
Aprire:
$9.88
Volume 24 ore:
345.44K
Relative Volume:
0.33
Capitalizzazione di mercato:
$585.91M
Reddito:
$217.11M
Utile/perdita netta:
$-651.19M
Rapporto P/E:
-0.7452
EPS:
-12.99
Flusso di cassa netto:
$-387.26M
1 W Prestazione:
+6.87%
1M Prestazione:
+14.88%
6M Prestazione:
-30.87%
1 anno Prestazione:
-18.36%
Intervallo 1D:
$9.5139
$9.93
Intervallo di 1 settimana:
$9.03
$11.10
Portata 52W:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Nome
Ginkgo Bioworks Holdings Inc
Settore
Industria
Telefono
(877) 442-5362
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Confronta DNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
9.67 | 596.81M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.77 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.30 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.84 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.09 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.08 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-15 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-05-10 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-02 | Downgrade | Goldman | Neutral → Sell |
| 2023-05-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-10-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-02-23 | Iniziato | Goldman | Neutral |
| 2022-02-01 | Iniziato | BofA Securities | Neutral |
| 2022-01-28 | Iniziato | BofA Securities | Buy |
| 2022-01-07 | Iniziato | BTIG Research | Buy |
| 2021-11-29 | Iniziato | Jefferies | Buy |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-10-12 | Iniziato | William Blair | Outperform |
| 2021-09-20 | Iniziato | HSBC Securities | Buy |
Mostra tutto
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Bearish Setup: What are the future prospects of Ginkgo Bioworks Holdings IncJuly 2025 Price Swings & Safe Capital Investment Plans - baoquankhu1.vn
Ginkgo Bioworks Holdings, Inc. (DNA) stock drops despite market gains: Important facts to note - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 12.2%Here's What Happened - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Trading Down 8.8%Time to Sell? - MarketBeat
Portfolio Recap: Will Ginkgo Bioworks Holdings Inc benefit from rising consumer demand2025 Earnings Surprises & Weekly High Return Stock Opportunities - baoquankhu1.vn
Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY: DNA - FinancialContent
Discipline and Rules-Based Execution in DNA Response - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know - sharewise.com
Aug Sentiment: Why is Ginkgo Bioworks Holdings Inc stock going upMarket Growth Review & Target Return Focused Picks - baoquankhu1.vn
Twist Bioscience and Ginkgo Bioworks update 2022 partnership - MSN
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference - Chartmill
Exit Recap: Will Ginkgo Bioworks Holdings Inc. stock recover faster than marketWeekly Trading Summary & Fast Gain Swing Alerts - Bộ Nội Vụ
Why The Narrative Around Ginkgo Bioworks Holdings (DNA) Is Shifting After New Fair Value Reset - Yahoo Finance
Why hedge funds are buying Ginkgo Bioworks Holdings Inc. stock2025 Investor Takeaways & Technical Pattern Alert System - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) rises as market takes a dip: Key facts - MSN
Can Ginkgo Bioworks Holdings Inc. stock beat analyst upgradesPortfolio Gains Report & Growth Focused Entry Point Reports - Улправда
Is Ginkgo Bioworks Holdings Inc. stock overvalued by current metricsQuarterly Growth Report & Community Trade Idea Sharing - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) stock dips while market gains: Key facts - MSN
Can Ginkgo Bioworks Holdings Inc. Class stock surprise markets with earnings2025 Analyst Calls & Growth Focused Stock Pick Reports - Улправда
How rising interest rates impact Ginkgo Bioworks Holdings Inc. stock2025 Macro Impact & AI Enhanced Market Trend Forecasts - Улправда
Bull Bear: How Ginkgo Bioworks Holdings Inc. stock trades before earningsEarnings Trend Report & Weekly High Potential Alerts - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - sharewise.com
Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weakness2025 Market Overview & Long-Term Investment Growth Plans - Улправда
Aug Gainers: Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessInflation Watch & Safe Entry Momentum Tips - Улправда
TD Cowen Lowers Ginkgo Bioworks (NYSE:DNA) Price Target to $12.00 - MarketBeat
How Ginkgo Bioworks Holdings Inc. Class stock reacts to Fed tighteningEarnings Performance Report & Fast Exit Strategy with Risk Control - Улправда
Analyst Downgrade: Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessTrend Reversal & Trade Opportunity Analysis Reports - ulpravda.ru
Ginkgo Bioworks realigns leadership, shifts COO responsibilities - MSN
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks announces COO transition and operational leadership changes By Investing.com - Investing.com Australia
Ginkgo Bioworks announces COO transition and operational leadership changes - Investing.com
Is Ginkgo Bioworks Holdings Inc a good long term investmentInsider Trading Compliance & Affordable Trading Techniques - earlytimes.in
Penny Stocks That Will Make You Richcareer Html Definition Characteristics & How To Invest - shababeek.org
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts - sharewise.com
Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0% - simplywall.st
Liquidity Mapping Around (DNA) Price Events - Stock Traders Daily
Ginkgo Bioworks announces operating leadership transition effective January 2026 By Investing.com - Investing.com India
Ginkgo Bioworks announces operating leadership transition effective January 2026 - Investing.com
Ginkgo Bioworks Announces COO Transition - TradingView — Track All Markets
Ginkgo Bioworks shifts operating duties in leadership restructure - StreetInsider
Ginkgo Bioworks (NYSE: DNA) realigns leadership as Shetty refocuses on lab - Stock Titan
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach - Sahm
Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans - Sahm
Ginkgo Bioworks Holdings, Inc. Announces Executives Changes, Effective January 1, 2026 - marketscreener.com
Ginkgo Bioworks, Carnegie Mellon Partner on At-Home Cancer Detection Technology - marketscreener.com
Ginkgo Bioworks Partners with CMU to Develop Innovative Cancer Detection Technology - Intellectia AI
Ginkgo Bioworks partners with CMU on innovative cancer detection By Investing.com - Investing.com Canada
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):